NEW YORK, Oct 25 (Reuters) - Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) on Tuesday said it had named longtime company executive John Deiriggi to the new post of Chief Operating Officer of its Mylan Pharmaceuticals unit, which makes generic medicines.
